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ABSTRACT   
The understanding of the mechanism of apoptosis is important to improve the use of 
stem cells for the treatment of neurodegenerative disorders. Sphingolipids are bioactive 
molecules involved in the regulation of cell fate. In HN9.10e embryonic hippocampal 
cells, serum deprivation induces apoptosis preceded by sphingomyelinase activation and  
raise of ceramide levels. Increasing evidence indicates that individual ceramide species 
regulated by specific pathways in distinct subcellular compartments might carry out 
distinct cellular functions but the  ceramides species involved in embryonic 
hippocampal cell death induced by  growth factor deprivation are unknown.  In the 
present paper,  by using the UFLC-MS/MS methodology, we have investigated the 
effect of serum deprivation on the lipid profile in HN9.10e cells. At 48 h of serum 
deprivation we detected a decrease in cholesterol and increase in sphingosine-1-
phoshate 18:1, phosphatidylcholine 18:1 18:0, sphingomyelin 18:1 16:0 and in 
ceramides 18:1 16:0; we also found an increase in saturated/unsaturated fatty acid ratio 
in sphingomyelin. We hypothesize that the rearrangement of sphingo- and glycerolipids 
with increase of saturated fatty acids in serum-deprivated neural cells might represent a 
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Cell transplantation has been shown to be an effective therapy for central 
nervous system disorders in animal models. However, certain challenges remain to be 
resolved before the use of stem cells for neurological diseases can be fully realized, 
which include the need to optimize survival and function of neural derivatives upon 
long-term differentiation in vitro and in vivo  [1].  As apoptosis plays a central role in 
the fate of transplanted cells, it is necessary to increase the knowledge of the 
mechanisms of apoptosis of stem cells and neural progenitors. 
Sphingolipids are structural and bioactive molecules involved in the regulation 
of proliferation, survival, differentiation and cell death [2]. Sphingolipids include 
several classes of molecules, such as sphingosine (Sph), sphingosine-1-phosphate 
(Sph1P), ceramide (Cer), glucosylceramide, and sphingomyelin (SM) [3]. In particular 
sphingomyelin (SM) influences cell fate by regulating growth, survival, differentiation 
and apoptosis [4]. SM is synthesized by sphingomyelin-synthase (SM-synthase) by 
using phosphatidylcholine (PC) as source of phophorylcholine (PPC) and releasing 
diacylglycerol (DAG); SM is catabolized by sphingomyelinase (SMase) producing 
ceramide and PPC. In addition,  SM can be used as source of PPC for PC synthesis, in 
the presence of  DAG, releasing ceramide by reverse-sphingomyelin-synthase  [5]. It is 
worthy to note that the crosstalk between glycerophospholipids and sphingolipids 
controls important lipid mediators such as ceramide and DAG [6]; sphingolipid and PC 
are interconvertible in biological systems and their relative levels are important in 
determining cell fate [4].  
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Furthermore,	hydrolysis	of	PC	by	phospholipase	D		is	a	source	of		choline,	which	is	not	only	used	for	the	synthesis	of	the	neurotransmitter	acetylcholine		in	cholinergic	neurons	[7], but it is possibly involved in maturation and differentiation of 
astroglial cells in vitro independently of acetylcholine [8,9].	The multiple pathways of 
ceramide generation led  to the hypothesis that individual ceramide molecular species 
are regulated by specific biochemical pathways in distinct subcellular compartments and 
they carry out distinct functions [10]. Saturated fatty acids of SM favour the formation 
of Van der Waals interactions between SM and cholesterol (CHO) [5,11] to form 
membrane lipid rafts that act as platforms for specific protein and lipid sorting and 
regulators of cell signalling.   
We have previously demonstrated that serum deprivation induces a time-dependent 
decrease in cell viability and increase in the cell percentage in G1 phase of the cell cycle 
via SM metabolism [12-15]. Serum deprivation is able to enhance spontaneous or 
growth factor-induced differentiation in neural cells, including astrogial cells [16,17] 
but no data exist on the effect of serum deprivation on lipid profile so far. In the present 
paper we have investigated this aspect in HN9.10e cells by UFLC-MS/MS. We have 
found a strong decrease of CHO and an increase of saturated PC, ceramide and Sph1P; 
we also observed an increase in SM saturated/unsaturated fatty acid ratio. We 
hypothesize that the low level of intracellular CHO might result from the failure of 
incorporation into the cells due to lack of its availability during serum deprivation. We 
hypothesize that the rearrangement of sphingo- and glycerolipids and  the increase of 
saturated fatty acids in response to the loss of CHO might represent a response to hold 
CHO inside the cell. 	
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2. Material and Methods  
2.1. Reagents 
Dulbecco’s modified Eagle’s medium (DMEM), methanol, 3-(4,5-dimethyl-thiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT),  2-propanol, metyl-tert-butyl ether, formic 
acid, chloroform, cholesterol (CHO) were obtained from Sigma Chemical Co. (St. 
Louis, MO, USA.); SM 18:1 12:0, SM 18:1 16:0, SM 18:1 18:1, SM 24:0, ceramide 
18:1 16:0, ceramide 18:1 18:0, ceramide 18:1 20:0, ceramide 18:1 24:0 were purchased 
from Avanti (Avanti Polar, Alabaster, AL, USA). Fetal calf serum was from Euroclone 
(Pero, Milano, Italy). 
 
2.2. Cell culture 
 
HN9.10e cells were were grown in DMEM, supplemented with 10% fetal bovine 
serum, 2 mM L-glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin and 2.5 µg/ml 
amphotericin B (fungizone). Cells were maintained at 37 °C in a saturating humidity 
atmosphere containing 95% air 5% CO2. Cells were plated in 10 cm Æ dishes and 
incubated with 10% (control) or 0.2% fetal calf serum for 48 h (deprived) as previously 
described [12-14] and frozen immediately. 
 
2.3. Lipid extraction and separation 
 
 Lipids were extracted as in [18]. Lipid species were separated and measured by 
ultraperformance liquid chromatography tandem mass spectrometry [19] by using Ultra 
Performance Liquid Chromatography system  (LC20AD prominence, SIL20AC ht 
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autosampler, DGU20A3 degasser, CTO20A column oven) tandem Mass Spectrometer 
Applied Biosystem (Shimadzu Italy s.r.l., Italy). The samples were separated on a 
Phenomenex Kinetex phenyl-hexyl 100 A column (50 x 4,60 mm diameter, 2.6 µm 
particle diameter) with precolumn security guard Phenomenex ULTRA phenyl-hexyl 
4.6. For sphingomyelins, column temperature was set at 50°C, flow rate 0.9 mL/min. 
Solvent A was 1% formic acid; solvent B  100% isopropanol containing 0.1% formic 
acid. Run was performed for  3 min in 50% solvent B and then gradient to reach 100% 
B in 5 min. The system has been reconditioned for 5 min with 50% B before the next 
injection. 
The sphingomyelin species were identified by using positive turbo ion spray and 
modality multipole reaction monitoring. The identification and analysis of CHO was 
conducted by atmosferic pressure chemical ionization (APCI) in positive ionization 
conditions and multipole ion scan modality as described in [20].  
 
2.4. Cell viability  
 
Ten thousand cells were plated in 96-well dishes, and cultured in the presence or 
absence of  Sph1P in medium containing 0.2 % , 1% and 10% FBS for 48 h.	Cell 
viability was measured as MTT reduction as previously described [12-13].  Briefly, 0.5 
mg/ml final concentration MTT was added to the culture medium, plates were incubated 
at 37°C for 30 min and then medium was replaced with 100 µl dimethylsulfoxide to 
solve the formazan salts. Absorbance was measured at 570 nm and values were 
normalized considering  the average of absorbance of the control sample.  
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2.5. Protein content 
Total protein concentration was determined spectrophotometrically at 750 nm by using 
bovine serum albumin as a standard according to [21]. The method combines the 
reactions of copper ions with the peptide bonds under alkaline conditions and the 
oxidation of aromatic aminoacids by the Folin–Ciocalteu reagent. 
2.6. Statistical analysis 




3. Results  
 
3.1. Serum deprivation induces changes in the content of cholesterol, sphingomyelin, 
ceramide and phosphatidylcholine 
 
We have analyzed for the first time the change of lipid profile in HN9.10e cells 
after serum deprivation by using UFLC-MS/MS	systems, a methodology that allows to 
obtain simultaneous quantitative analysis of CHO, PC and sphingolipids [20]. Serum 
deprivation induces a decrease  in CHO content to 48% of control samples (Fig.1a). We 
have also analyzed the most common PC, ceramide and SM species by using external 
calibrators for each species (PC 16:0 18:1, PC 16:0 20:4, PC 18:1 18:0, ceramide  16:0, 
ceramide 18:0, ceramide 20:0, ceramide 24:0, SM 16:0, SM 18:1, SM 24:0) (Fig. 1 b-d). 
We have observed that serum deprivation induces an increase in the three species of PC 
analyzed, in SM 16:0 and 24:0, in ceramide 16:0 and a decrease in ceramide 24:0. No 
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significant variation of SM 18:1 and ceramide 20:0 has been found. Serum deprivation 
increases Sph1P content 1.89-fold compared to control (Fig. 1f). Exogenously added 0.1 
µM Sph1P does not modify the viability of cells grown on 10% containing medium or 
serum-deprived cells, as measured by MTT reduction assay However, 0.1 µM Sph1P 
does reduce viability when cells are cultured in 1% FBS for 48 h. The viability of cells 
cultured in low serum was 0.33 + 0.13 compared to  cells cultured in 10% FBS for the 
same period (1.00 + 0.22), whereas the presence of Sph1P reduced viability to 0.22 + 
0.09 (n=5 independent experiments performed in octuplicate, p<0.05).  
  
3.2. Serum deprivation-induced changes in SM species profile. 
 
To have a deeper insight of SM species containing saturated or unsaturated fatty 
acids, we have  evaluated the areas of all the peaks identified on the basis of their 
molecular weight.  A total of 55 species were investigated: SM 2:0, SM 4:0, SM 6:0, 
SM 8:0, SM 10:0, SM 10:1, SM 10:2, SM 10:3, SM 12:0, SM 12:1, SM 12:2, SM 12:3, 
SM 14:1, SM 14:2, SM 14:3, SM 16:2, SM 18:2, SM 18:3, SM 20:1, SM 20:2, SM 
20:3, SM 22:3, SM 22:4, SM 22:5, SM 24:5, SM 24:6, SM 26:1, SM 26:5, SM 26:6, 
SM 28:0- SM 30:8 were absent. Twenty-four peaks were detected.  Significant 
differences in the levels of various lipid molecular species were found between control 
and serum-deprived samples (Table 1). We have compared the changes in the levels of 
SM species containing saturated and unsaturated fatty acids. As reported in Fig. 2 the 
SM saturated fatty acids were 1.24-fold higher and SM unsaturated fatty acid 1.46 lower 
in serum-deprived samples than in controls. Thus, saturated /unsaturated fatty acid ratio 
was 2.02 in controls and 3.68 in serum-deprived samples (Fig. 2a). Among unsaturated 
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fatty acids, the monounsaturated, two-unsaturated and four-unsaturated decreased 2.13-
fold, 2.71-fold, and 1.71-fold respectively whereas three-, five- and six- unsaturated did 




Serum deprivation decreases significantly CHO content in HN9.10e cells. This 
reduction might be due to the lack of availability of CHO in the culture medium. It has 
been demonstrated that cultured cells use CHO present in the medium to proliferate, and 
that high CHO levels stimulate cell growth whereas CHO synthesis inhibitors arrest  
cell cycle progression and alter differentiation and/or apoptosis [22]. It is known that 
CHO is linked by Van der Waals interaction to SM and, more weakly, to PC to form 
lipid rafts that interact with  a variety of proteins involved in important cell functions 
[4].   CHO plays a crucial role in the generation of rafts, ordered domains in the plasma 
membrane that laterally segregate certain proteins, thus reducing their rate of lateral 
diffusion, allowing clustering and, consequently, signaling strength. Decrease in CHO  
may modify signal transduction mediated by raft-localized receptors. Under low CHO 
conditions, mature hippocampal neurons exhibit  increased TrkB activity, the most 
prominent neurotrophin receptor expressed in hippocampus [23]. CHO  loss seems to 
induce neuronal survival in both acute and chronic stress  [24]. Whether this protective 
mechanism is also working in embryonic hippocampal neurons is not known. 
Since SM metabolism plays a critical role in serum deprivation-induced 
apoptosis in HN9.10e cells, we have analyzed the relative levels of the various 
sphingolipids and PC. In particular,  serum withdrawal increases ceramide 16:0 content 
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2.26-fold, decreases that of ceramide 24:0 without modifying ceramide 20:0 content   
compared to control cells. A raise in ceramide 16:0 has been observed in a variety of 
apoptosis-induced models including radiation-induced apoptosis and hormone 
deprivation in prostate cancer cells  [25-26]. In these models of apoptosis, a later  
increase in ceramide 24:0 has been found  [27]. By contrast, this species decreases  
(0.15-fold that of control cells) after 48 h of serum deprivation while SM 24:0 increases.  
Our data clearly show an increase in SM containing saturated long-chain fatty 
acids (22:0, 24:0, 26:0) (Table 1) and a decrease in SM containing unsaturated fatty 
acids. It is worth noting that we have not found any significant change in SM-synthase 
activity 48 hours after serum deprivation when we have used a pool of ceramides as 
substrate [14].  Possibly, this result could reflect, at least in part, the distinct  effects of 
serum deprivation on different SM species. Whether this result is due to a failure of  
putative serum-deprived activated SM-syntase(s) to use this mixture as substrate is not 
clear for the moment.  Differently, the reduction of almost all species of unsaturated SM 
might be due to the high activity of SMase found following 48 hours of serum 
deprivation  [14].  Since saturated SM binds CHO to form the lipid rafts and the 
depletion of CHO disorganizes these structures [28], it is possible to hypothesize that 
the reduction of CHO incorporation in HN9.10e cells, due to lack of availability in 
serum-deprived culture medium, induces an increase of saturated long-chain SM to 
capture the intracellular CHO. This could be a response of the cell to ensure the 
presence of lipid rafts in the membranes, important for signal transduction, in order to 
limit the serum deprivation-induced damage. 
Serum deprivation increases Sph1P content 1.89 -fold compared to controls. 
Sph1P has been usually involved in proliferation and survival. However,  addition of 
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Sph1P reduces viability of HN9.10e cells (this paper) and primary hippocampal cells 
[29]. Anti-apoptotic effects of Sph1P appear to be correlated with the action of 
sphingosine kinase 1. It has been reported that Sph1P induces neuronal death when 
generated by sphingosine-kinase2 and when Sph1P is accumulated due to Sph1P-lyase 
deficiency [30].   
In summary, we have identified some modifications of the lipid profile in serum-
deprived HN9.10e cells. The decrease in CHO suggests that reorganization of rafts 
might play an important role. Increasing knowledge on the lipid species  involved in 
serum deprivation-induced apoptosis might be useful for improving neuroblast survival 
after  stem cell therapy in  neurodegenerative diseases.  
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Fig. 1. Effect of serum deprivation on different lipid species. 
Cells were serum-deprived for 48 or grown in 10% FBS. Lipids were quantified as 
described in Materials and Methods. Data are expressed as mean +  SD (n=5) 
 
Fig. 2. Quantification of fatty acids of sphingomyelin  
Cells were serum-deprived for 48 or grown in 10% FBS. Lipids were quantified as 
described in Materials and Methods. Data are expressed as as mean +  SD (n=5) . Sat: 
saturated; Unsat: unsaturated.  
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Composition of SM 
SM species       control      Serum deprivation  Significance 
 
Saturated 
SM 14:0    1.60 + 0.45     0.79 + 0.66                     ns 
SM 16:0    12.68 + 1.65  17.25 + 0.75    p< 0.05 
SM 18:0    7.18 + 2.68      9.45 + 1.02       ns 
SM 20:0  34.12 + 4.63  26.85 + 1.03                 p< 0.05 
SM 22:0  56.47 + 4.01  76.67 + 2.22    p< 0.001 
SM 24:0  17.88 + 0.27   26.80 + 1.68                 p< 0.001 
SM 26:0    3.52 + 0.10    7.85 + 0.53    p< 0.001 
 
Unsaturated 
SM 16:1    1.56 + 0.86    1.06 + 0.15                      ns 
SM 16:3    0.73 + 0.05                 4.38 + 0.65                  p< 0.001 
SM 16:4    2.77 + 0.36    3.10 + 0.16         ns 
SM 18:1    1.03 + 0.20     0.86 + 0.17         ns 
SM 18:4    3.74 + 0.95    1.79 + 0.25    p< 0.01 
SM 20:4    4.18 + 0.61    2.88 + 0.46                      ns 
SM 20:5  13.40 + 2.57               10.90 + 0.32         ns 
SM 22:1    6.71 + 0.24                 1.96 + 0.72    p< 0.001 
SM 22:2    3.24 + 0.63     1.58 + 0.99    p< 0.05 
SM 22:6    2.59 + 0.92     3.69 + 1.44          ns 
SM 24:1    6.82 + 1.52      3.68 + 0.39     p< 0.01 
SM 24:2    5.11 + 0.95     1.50 + 0.16                  p< 0.001 
SM 24:3    3.46 + 1.12    2.79 + 0.87                        ns 
SM 24:4    3.93 + 0.82                 1.02 + 0.20     p< 0.001 
SM 26:2                        1.94 + 0.28                 0.71 + 0.16                  p<  0.05 






Legend Table 1. 
SM were quantified as described in Materials and Methods. Data are expressed as mean 
+  SD (n=5) control or serum deprived samples (µg/mg protein). 
